Senior Clinical Trial Manager (Sr. CTM)
- Employer
- Nurix Therapeutics
- Location
- Brisbane, California
- Posted date
- Sep 28, 2026
View more categories
- Discipline
- Clinical, Clinical Research, Clinical Trials
- Required Education
- Bachelors Degree
- Position Type
- Full time
Job Details
Senior Clinical Trial Manager (Sr CTM)
You’ve run trials well — now run more of them, and help others do the same. You’ll manage a portfolio of trials or a full region, own vendor strategy end-to-end, and become the person other CTMs turn to when something’s stuck.
Position Description
This individual manages clinical regions and/or multiple trials simultaneously, with broad involvement in work central to Nurix’s strategic goals, and plays a key role in developing junior clinical operations staff.
The Opportunity
Own operational strategy across multiple clinical trials and/or a full geographic region
Shape protocol strategy and provide senior input on study design and data collection approach
Lead vendor/CRO selection strategy and own contract negotiation leverage across trials
Serve as the escalation point for vendor or site issues CTMs can’t resolve on their own
Own program-level budget forecasting and proactively flag financial risk across the portfolio
Mentor and develop CTMs and CTAs, providing hands-on guidance and informal supervision
Lead audit readiness strategy and serve as the point person across multiple trials during inspections
Represent Clinical Operations at the program or franchise level, and represent Nurix externally at professional events
Anticipate risk across the trial portfolio and shape process or strategy to prevent issues before they surface
Lead cross-functional strategic initiatives rather than simply participating in them
What You’ll Bring
S./B.A. in biological sciences with 8-10+ years of relevant industry experience
Ability to travel as required for the program (25%)
Deep working knowledge of FDA, EMA, ICH, and GCP regulations and guidelines
Proven experience managing global trials or multi-region programs
Track record leading vendor/CRO relationships at a strategic, not just operational, level
Experience mentoring or developing junior CTMs/CTAs
Strong executive presence and ability to influence without direct authority
Comfortable operating with minimal oversight and setting direction for others
Outstanding organizational skills, able to manage a portfolio of trials simultaneously
Thrives in a fast-paced, small-company environment, adjusting priorities as needed
Salary Range: $181,900 – $193.827 annually
The posted range applies to roles based in the San Francisco Bay Area and reflects local market conditions. Where an offer lands within that range depends on the candidate’s relevant experience, technical expertise, and how their background aligns with the role’s requirements.
Location: Onsite – Brisbane, CA
Fit with Nurix Culture and Values
Strong team orientation; highly collaborative
Solutions and results-oriented focus
Hands-on approach; resourceful and open to diverse points of view
About Nurix Therapeutics
Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines, the next frontier in innovative drug design aimed at improving treatment options for patients with cancer and inflammatory diseases. Powered by a fully AI-integrated discovery engine capable of tackling any protein class, and coupled with unparalleled ligase expertise, Nurix’s dedicated team has built a formidable advantage in translating the science of targeted protein degradation into clinical advancements. Nurix aims to establish degrader-based treatments at the forefront of patient care, writing medicine’s next chapter with a new script to outmatch disease.
Company
Nurix Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. Leveraging Nurix’s extensive expertise in E3 ligases together with its proprietary DNA-encoded libraries, Nurix has built DELigase, an integrated discovery platform to identify and advance novel drug candidates targeting E3 ligases, a broad class of enzymes that can modulate proteins within the cell. Nurix’s drug discovery approach is to either harness or inhibit the natural function of E3 ligases within the ubiquitin proteasome system to selectively decrease or increase cellular protein levels.
Nurix’s wholly owned pipeline comprises targeted protein degraders of Bruton’s tyrosine kinase, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, an E3 ligase that regulates T cell activation. Nurix is headquartered in San Francisco, California.
- Phone
- 415-660-5320
- Location
- 1700 Owens Street
Suite 205
San Francisco
California
94158